SCHEMBL6765743

SCHEMBL6765743

O=S(=O)(c1ccc(CBr)cc1)n1cccc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 2/20 0.58
CA2 P00918 2/20 0.58
FBP1 P09467 1/20 0.47
TP53 P04637 1/20 0.42
NAMPT P43490 1/20 0.40
TRPA1 O75762 1/20 0.38
ALDH1A1 P00352 1/20 0.38
TSHR P16473 1/20 0.38
HTR6 P50406 2/20 0.36
CES2 O00748 1/20 0.36
CES1 P23141 1/20 0.36
USP2 O75604 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
PKM P14618 2/20 0.33
RAPGEF4 Q8WZA2 2/20 0.33
GAA P10253 1/20 0.33
CA12 O43570 1/20 0.33
CA9 Q16790 1/20 0.33
MEN1 O00255 1/20 0.33
HTT P42858 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3018059 0.78 CA2 (0.64) CA1CA2FBP1PKMGAA
SCHEMBL752816 0.74 CA1 (0.65) CA1CA2FBP1ALDH1A1TSHR
SCHEMBL1364805 0.74 CA1 (1.00) CA1CA2FBP1ALDH1A1PKM
SCHEMBL1148233 0.72 HTR6 (0.47) CA1CA2TRPA1ALDH1A1TSHR
SCHEMBL3341489 0.72 USP2 (0.68) ALDH1A1TSHRUSP2SMN1; SMN2PKM
SCHEMBL22217089 0.72 USP2 (0.62) ALDH1A1TSHRUSP2SMN1; SMN2PKM
SCHEMBL21806794 0.70 CA1 (0.54) CA1CA2TP53ALDH1A1HTR6
SCHEMBL5018987 0.70 USP2 (0.71) ALDH1A1TSHRUSP2SMN1; SMN2GAA
SCHEMBL8996770 0.70 TSHR (0.42) CA1CA2TP53TRPA1ALDH1A1
SCHEMBL2217200 0.69 HTR6 (0.61) CA1CA2NAMPTTRPA1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106061480-A Therapeutic inhibitory compounds 莱福斯希医药公司 2016-10-26 CN disclosed
US-6686353-B1 PREVENTING BLOOD MONOCYTES AND LYMPHOCYTES FROM INFILTRATING TISSUE TEIJIN INTELLECTUAL PROPERTY CENTER LIMITED (JP) 2004-02-03 US disclosed
EP-0914319-B1 DIARYLALKYL CYCLIC DIAMINE DERIVATIVES AS CHEMOKINE RECEPTOR ANTAGONISTS TEIJIN LTD (JP) 2001-11-21 EP disclosed
EP-0914319-A1 DIARYLALKYL CYCLIC DIAMINE DERIVATIVES AS CHEMOKINE RECEPTOR ANTAGONISTS TEIJIN LIMITED (JP) 1999-05-12 EP disclosed
WO-1997044329-A9 DIARYLALKYL CYCLIC DIAMINE DERIVATIVES AS CHEMOKINE RECEPTOR ANTAGONISTS 1998-03-12 WO disclosed
WO-1997044329-A1 DIARYLALKYL CYCLIC DIAMINE DERIVATIVES AS CHEMOKINE RECEPTOR ANTAGONISTS TEIJIN LIMITED (JP) 1997-11-27 WO disclosed